Seeking progress in disease modification in Parkinson disease
Codrin Lungu, Jesse M. Cedarbaum, Ted M. Dawson, E. Ray Dorsey, Carlos Alberto Faraco, Howard J. Federoff, Brian Fiske, Robert J. Fox, Andrew M. Goldfine, Karl Kieburtz, Eric A. Macklin, Helen Matthews, Gary Rafaloff, Rachel Saunders‐Pullman, Nina F. Schor, Michael A. Schwarzschild, Beth-Anne Sieber, Tanya Simuni, D. James Surmeier, Amir P. Tamiz, Milton H. Werner, Clinton B. Wright, Richard Wyse
Topics & Concepts
DiseaseStakeholderParkinson's diseaseMedicineClinical trialDrug developmentEngineering ethicsManagement sciencePolitical scienceDrugPublic relationsEngineeringPsychiatryPathologyParkinson's Disease Mechanisms and TreatmentsNuclear Receptors and SignalingPhosphodiesterase function and regulation